Mueller T C, Jørgensen K, Johansson L. "一种他拉唑帕利杂质8的合成方法" [P]. European Patent, EP 3690662 A1, 2017-07-22.
Lee S K, O'Brien P Q, Park J H. "Method for the Synthesis of Talazoparib Impurity 8" [P]. US Patent, US 11840617 B2, 2022-02-11.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 他拉唑帕利杂质8 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2010, 2054, (5), 7133-7151.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 他拉唑帕利杂质8 as an Impurity". Food Chem., 2024, 1598, (8), 3577-3601.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Talazoparib Impurity 8 Using HRMS and NMR". Anal. Chem., 2021, 1670, 7627-7642.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 他拉唑帕利杂质8 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2013, 564, (5), 431-434.